Helix Biopharma Corp. Begins Trading on the OTCQX International Market Listin... ( AURORA Ontario June 23 /- Helix BioPh...)

Helix Biopharma Corp. Begins Trading on the OTCQX International Market Listing as HXBPF

Date:6/23/2009

AURORA, Ontario, June 23 /PRNewswire-FirstCall/ -- Helix BioPharma Corp. (TSX, FSE: HBP; OTCQX: HXBPF) announced today that it has commenced trading in the U.S. on the OTCQX International Market under the ticker symbol HXBPF. Investors can find real-time quotes, disclosure and financial information about the OTCQX International Market at www.otcqx.com.

"Our OTCQX listing provides Helix with enhanced local access to the largest capital market in the world," said John Docherty, president and chief operating officer of Helix. "Following our recently announced 20-F SEC registration, our OTCQX listing is another important steppingstone towards our ultimate goal of a listing on a major U.S. stock exchange such as The NASDAQ."

U.S. investment bank, Merriman Curhan Ford, will serve as Helix's Principal American Liaison ("PAL") on the OTCQX and will be responsible for providing guidance on the Company's continuing OTCQX-listing requirements and arranging a comprehensive suite of U.S. capital market services.

"Merriman is very pleased to sponsor Helix and to serve as their PAL," said Stephen Nash, managing director and head of Merriman Curhan Ford's OTCQX Advisory Group. "With our leadership in the advising, financing and trading of small capitalization health care companies, Merriman is uniquely positioned to help raise this exciting company's profile amongst U.S. investors."

About Helix BioPharma Corp.

Helix BioPharma Corp. is a biopharmaceutical company specializing in the field of cancer therapy. The Company is actively developing innovative products for the prevention and treatment of cancer based on its proprietary technologies. Helix's product development initiatives include its Topical Interferon Alpha-2b and its novel L-DOS47 new drug candidate. Helix is listed on the TSX and FSE under the symbol "HBP" and on the O
'/>"/>

SOURCE Helix BioPharma Corp.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4
Related medicine news :

1. Helix BioPharma Reports on 2008 Annual General Meeting and Provides Corporate Update
2. CSL Behrings Helixate(R) FS Now Available in 2000 IU Vial Size to Improve Patient Convenience, Encourage Compliance
3. Sinobiopharma Receives Trademark Approval and Authentication From Chinese Government For Its Tai Drug Series
4. Keryx Biopharmaceuticals Inc. Regains Compliance With NASDAQ Listing Requirements
5. AlphaRx and Gaia BioPharma Provide GAI-122 Development Update
6. PDL BioPharma Announces Record Date for October 1 Dividend Payment
7. Keryx Biopharmaceuticals, Inc. Receives Extension for Nasdaq Listing Compliance
8. SAFE-BioPharma Webinar Featuring ARX's Digital Signatures Combined with Microsoft SharePoint for Bio-Pharma industry
9. Prix Galien USA Now Accepting Nominations for Premiere Biopharmaceutical Industry Award
10. The Sage Group Widens Strategic Role to Assist HemispherX Biopharma in Pandemic Influenza Initiatives as Pacific Rim/Japan Treatment/Prevention Programs Accelerate
11. SAFE-BioPharma Webinar Featuring ARX's Digital Signature Solution and Adobe LiveCycle Combined Solution

Post Your Comments:

(Date:12/5/2009)AVIVA today announced the launch of International Solutions, an innovative new international private medical insurance plan which follows the acclaimed modular design of its UK equivalent. In addition

(Date:12/4/2009)PALO ALTO, Calif., Dec. 4 Varian Medical Systems (NYSE: VAR ) announced today that its Board of Directors has set the regular 2010 Annual Meeting of Stockholders for February 11, 2010 with a record

(Date:12/4/2009)SAN FRANCISCO, Dec. 4 Medithrive, Inc. has won the Patient,s Choice Award as the favorite dispensary in the SF Bay Area by popular vote conducted by the online website, www.weedmaps.com. Despite on

(Date:12/4/2009)SCOTTSDALE, Ariz., Dec. 4 Healthcare Trust of America, Inc. ("HTA"), a self-managed, non-traded, real estate investment trust, announced the execution of a purchase and sale agreement to acquire a th

(Date:12/4/2009)ANAHEIM, Calif., Dec. 4 Pamela Bowen, Chief Information Officer at Crescent Healthcare, was selected as a finalist for the "Chief Innovation Officer" Appy Award for transforming Crescent,s business w

Breaking Medicine News(10 mins):Health News:AVIVA's Private Health Insurance Products Solutions Go International 2 Health News:Varian Medical Systems Schedules Annual Stockholder Meeting in Palo Alto 2 Health News:Healthcare Trust of America, Inc. Executes Agreement to Acquire a 92,500 Square Foot Medical Office Portfolio Located in Texas and Indiana 2 Health News:Crescent CIO '09 Dreamforce Conference Speaker and Award Finalist 2

[0] AVIVA's Private Health Insurance Products Solutions Go International [0] Varian Medical Systems Schedules Annual Stockholder Meeting in Palo Alto [0] Medithrive Voted #1 Medicinal Marijuana Dispensary in Bay Area [0] Healthcare Trust of America, Inc. Executes Agreement to Acquire a 92,500 Square Foot Medical Office Portfolio Located in Texas and Indiana [0] Crescent CIO '09 Dreamforce Conference Speaker and Award Finalist

...ck bowel; warnings not mandated on packages, study...ws) -- Parents need to be better warned about pote...wing toys with magnets before shopping for present...gestive tract, the need for surgery, and even deat...

...rescription Prenatal Vitamins , , PrimaCare O...ensive once-daily prescription prenatal vitamin in...nd EPA , , ST. LOUIS, Dec. 17 KV Pharmaceuti...al vitamins - has enhanced the formulation of one ...

...od of use to treat mildly infected diabetic foot u... double-blinded multi-center clinical trials of pe...ARMACEUTICALS, INC. (OTC Bulletin Board: ACCP) an...ild diabetic foot infection were published in the ...

...swire-FirstCall/ - MDS Inc. (TSX: MDS; NYSE: MDZ... the global life sciences markets, today reported ...ear-end results for the period ended October 31, 2...Services goodwill that was previously announced on...

...SynCare, LLC, today announced that,Ian Duncan has ...-renowned,author and expert in the field of diseas...ings a wealth of experience and knowledge to the S..."Ian is a pioneer in the use of,risk-adjustment an...

... mPay Gateway, a Minneapolis, MN company specia... today that a Minneapolis-area primary care clinic...ceivable by more than 50% after successfully imple...amatic A/R reduction within 12 weeks. , ...

Magnets in Kids' Toys Pose Broad Dangers KV Pharmaceutical Launches Enhanced Formulation of PrimaCare ONE(R)Pexiganan Phase 3 Clinical Trials Results Published in December Issue of CID MDS Reports Preliminary Fourth Quarter 2008 Results SynCare Announces Ian Duncan Joins Board of Directors Use of mPay Gateway Cuts Patient Receivables by 50%

(Date:12/4/2009)OMAHA, Neb., Dec. 4 Amber Pharmacy announced today that it received accreditation by the Accreditation Commission for Health Care, Inc. (ACHC) for specialized pharmacy services. For nearly 15 years,

(Date:12/4/2009)ANNAPOLIS, Md., Dec. 4 PharmAthene, Inc. (NYSE Amex: PIP ), a biodefense company developing medical countermeasures against biological and chemical threats, announced today the presentation of new d

(Date:12/4/2009)SAN DIEGO, Calif., Dec. 4 Suneva Medical, a privately-held aesthetic medical device company, today announced the appointment of Philip Ranker as Vice President and Chief Financial Officer. In this r

Breaking Medicine Technology:Amber Pharmacy Earns Accreditation From ACHC 2 PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 2 PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 3 PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 4 PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 5 Suneva Medical Announces Corporate Developments Including Appointment of Philip Ranker as Chief Financial Officer 2 Suneva Medical Announces Corporate Developments Including Appointment of Philip Ranker as Chief Financial Officer 3 Suneva Medical Announces Corporate Developments Including Appointment of Philip Ranker as Chief Financial Officer 4 New technique can help diagnose mesothelioma 55087 1 New technique can help diagnose mesothelioma 55087 2 Business Association in Denver Invites Award winning Author of ColorAlchemy to Provide Motivation to Energize Performance and Stimulate Success Using 55085 1 Business Association in Denver Invites Award winning Author of ColorAlchemy to Provide Motivation to Energize Performance and Stimulate Success Using 55085 2 Business Association in Denver Invites Award winning Author of ColorAlchemy to Provide Motivation to Energize Performance and Stimulate Success Using 55085 3 Business Association in Denver Invites Award winning Author of ColorAlchemy to Provide Motivation to Energize Performance and Stimulate Success Using 55085 4 Fragile period of childhood brain development could underlie epilepsy 55082 1 Fragile period of childhood brain development could underlie epilepsy 55082 2

[0] Amber Pharmacy Earns Accreditation From ACHC [0] PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop [0] Suneva Medical Announces Corporate Developments Including Appointment of Philip Ranker as Chief Financial Officer

...Utilized as an Adjuvant and Play Key Role in the,T...., March 20, 2007 /PRNewswire-FirstCall/ --,Immune...,BioSciences Holdings, Inc. , announced today that...nalog, Homspera, suggests that the,compound has po...,adjuvant. Studies performed in animal models of i...

...ronger FDA says drug review programs need more,mon...ire/ -- A new,estimate by the Alzheimer,s Associat...e living with Alzheimer,s disease -- a 10,percent ...ould more,than triple in the coming decades unless...bilitating illness. , The new numbers re-emphasize...

Other Medicine Technology:ImmuneRegen BioSciences Announces Promising Data on Homspera,Suggesting Potential as a Co-Therapeutic Agent 2 ImmuneRegen BioSciences Announces Promising Data on Homspera,Suggesting Potential as a Co-Therapeutic Agent 3 ImmuneRegen BioSciences Announces Promising Data on Homspera,Suggesting Potential as a Co-Therapeutic Agent 4 Alzheimer's Growth Shows Need for Increased FDA Funding 2 Alzheimer's Growth Shows Need for Increased FDA Funding 3

ImmuneRegen BioSciences Announces Promising Data on Homspera,Suggesting Potential as a Co-Therapeutic Agent Alzheimer's Growth Shows Need for Increased FDA Funding

Sapphire Surgical Knife With Titanium Handle

Capsule polisher aka Drysdale Nucleus Manipulator

Capsule polisher

Nucleus Spatula & Knife

Medicine Products:

Sapphire Surgical Knife With Titanium Handle Capsule polisher aka Drysdale Nucleus Manipulator Capsule polisher Nucleus Spatula & Knife

Helix Biopharma Corp. Begins Trading on the OTCQX International Market Listin...( AURORA Ontario June 23 /- Helix BioPh...),Health